INGN:NASDAQInogen, Inc Analysis
Data as of 2026-04-10 - not real-time
$6.45
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Inogen, Inc. shows a mixed picture. Technically the stock is perched just above its short‑term moving average and below its longer‑term average, while the relative strength index sits near the midpoint, suggesting neither extreme overbought nor oversold conditions. The MACD histogram is positive and the signal line is bullish, reinforced by an increasing volume trend, which together point to modest upside momentum toward the identified resistance zone.
Fundamentally, the company reports negative margins, a negative cash‑flow profile and a forward price‑to‑earnings ratio that is deeply negative, indicating earnings pressure. However, the price‑to‑book ratio is below one and the upside‑downside metric signals a sizable upside potential, aligning with the analyst consensus of a strong‑buy stance.
Fundamentally, the company reports negative margins, a negative cash‑flow profile and a forward price‑to‑earnings ratio that is deeply negative, indicating earnings pressure. However, the price‑to‑book ratio is below one and the upside‑downside metric signals a sizable upside potential, aligning with the analyst consensus of a strong‑buy stance.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Bullish MACD and rising volume
- Price holding above support level
- Analyst consensus of strong buy
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential revenue growth from portable oxygen market
- Improving valuation metrics relative to book
- Strategic board appointment indicating governance strength
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustained cash‑flow deficits and negative margins
- Regulatory and reimbursement uncertainties in medical devices
- Long‑term demand for home respiratory solutions
Key Metrics & Analysis
Financial Health
Revenue Growth2.00%
Profit Margin-6.52%
P/E Ratio-20.8
ROE-12.43%
ROA-6.35%
Debt/Equity9.09
P/B Ratio0.9
Op. Cash Flow$-11216000
Free Cash Flow$-21157376
Industry P/E26.0
Technical Analysis
TrendNeutral
RSI53.5
Support$5.86
Resistance$7.00
MA 20$6.32
MA 50$6.12
MA 200$7.04
MACDBullish
VolumeIncreasing
Fear & Greed Index86.21
Valuation
Target Price$12.67
Upside/Downside96.38%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.10
Volatility41.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.